Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

  1. Home

Managing serious and severe AEFIs post BCG vaccine

H5Content

Difference between anaphylaxis kit and AEFI kit

H5Content

Handling of anaphylaxis post BCG vaccine ​

H5Content

Other potential AEFI post BCG vaccine

H5Content

Very rare AEFIs reported with BCG Vaccine

H5Content

BCG vaccine and AEFIs

H5Content

Adult BCG Vaccine-Precautions to be taken to minimize AEFI

H5Content

Safety of BCG vaccine

H5Content

Strengthening AEFI surveillance​ for Adult BCG Vaccination

H5Content

Surveillance of Adverse Events Following Immunization for Adult BCG Vaccination

  • AEFI Case Definition​
  • Types of AEFI by Severity and Frequency
  • AEFI reporting formats - serious/severe
  • Reporting of AEFIs - serious/severe AEFIs
  • AEFI Committees for Adult BCG Vaccination
  • Strengthening AEFI surveillance​ for Adult BCG Vaccination
  • Safety of BCG vaccine
  • Adult BCG Vaccine-Precautions to be taken to minimize AEFI
  • BCG vaccine and AEFIs
  • Very rare AEFIs reported with BCG Vaccine
  • Other potential AEFI post BCG vaccine
  • Handling of anaphylaxis post BCG vaccine ​
  • Difference between anaphylaxis kit and AEFI kit
  • Managing serious and severe AEFIs post BCG vaccine
  • Adult BCG Vaccine-Reporting of AEFI

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International